Molecular Cytogenetics of t(12;21)(p13;q22)

References

• Rabbits T. H. Chromosomal translocations in human cancers. Nature 1994; 371: 143–149
   Web of Science ®Google Scholar
• Williams D. L., Look A. T., Melvin S. L., Roberson P. K., Dahl G., Flake T., Stass S. New chromosomal translocation correlate with specific immenophenotypes of childhood acute lymphoblastic leukemia. Cell 1984; 36: 101–109
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Williams D. L., Callihan T., Peiper S., Rivera G. K., Murphy S. B. Nonrandom involment of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69–75
   PubMed Web of Science ®Google Scholar
• Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237–2251
   PubMed Web of Science ®Google Scholar
• Berger R., Bernheim A., Le Coniat M., Vecchione D., Pacot A., Daniel M.-T., Flandrin G. Abnormalities of the short arm of chromosome 12 in acute nonlymphocytic leukemia and dysmyelopoietic syndrome. Cancer Genet. Cytogenet. 1986; 19: 281–289
   PubMed Web of Science ®Google Scholar
• Romana S. P., Le Coniat M., Berger R. t(12;21) A new recurrent translocation in acute lymphoblastic leukemia. Genes, Chromosomes and Cancer 1994; 9: 186–191
   PubMed Web of Science ®Google Scholar
• Chumakov I., Rigault P., Guillou S., Ougen P., Billaut A., Guasconi G., Gervy P., Le Gall I., Soularue P., Grinas L., Boulegueleret L., BellannÉ-Chantelot C., Lacroix B., Barillot E., Gesnouin O., Pook S., Vaysseix G., Frelat G., Schmitz A., Sambucy J.-L., Bosch A., Estivill X., Weissenbach J., Vignal A., Riethman H., Cox D., Patterson D., Gardiner K., Hattori M., Sasaki Y., Ichikawa H., Ohki M., Lepaslier D., Heilig R., Antonarakis S., Cohen D. Continuum of overlapping clones spanning the entire human chromosome 21q. Nature 1992; 359: 380–387
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307–316
   PubMed Web of Science ®Google Scholar
• Romana S. P., MauchauffÉ M., Le Coniat M., Chumakov I., Le Paslier D., Berger R., Bernard O. A. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 1995; 85: 3662–3670
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker F. G., Bohlander S. K., Hiebert S. W., Ward D. C., Bray-Ward P., Morgan E., Raimondi S. C., Rowley J. D., Gilliland D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 1995; 92: 4917–4921
   PubMed Web of Science ®Google Scholar
• Wasylyk B., Hahn S. L., Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 1993; 211: 7–18
   PubMedGoogle Scholar
• Ghysdael J. les régulateurs transcriptionnels de la famille Ets et leur implication dans les processus physiologiques normaux et la cancérogénèse. Path. Biol. 1995; 43: 202–207
   PubMedGoogle Scholar
• Golub T., Goga A., Barker G., Afar D., McLaughlin L., Bohlander S., Rowley J., Witte O., Gilliland D. G. Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Blood 1995; 264a, Abst.
   Google Scholar
• Lai Z.-C., Rubin G. M. Negative control of photoreceptor development in drosophila by the product of the yan gene, an ETS domain protein. Cell 1992; 70: 609–620
   PubMedGoogle Scholar
• Tei H., Nihonmatsu I., Yokokura T., Ueda R., Sano Y., Okuda T., Sato K., Hirata K., Fujita S. C., Yamamoto D. pokkuri, a Drosophila gene encoding an E-26-specific (Ets) domain protein, prevents overproduction of the R7 photoreceptor. Proc. Natl. Acad. Sci. USA 1992; 89: 6856–6860
   PubMed Web of Science ®Google Scholar
• O'Neill E. M., Rebay I., Tjian R., Rubin G. M. The activities of two Ets-related transcription factors requeired for drosophila eye development are modulated by Ras/MAPK pathway. Cell 1994; 78: 137–147
   PubMed Web of Science ®Google Scholar
• Rebay I., Rubin G. M. yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell 1995; 81: 857–866
   PubMedGoogle Scholar
• Buijs A., Sherr S., Van Baal S., Van Bezouw S., Van Der Plas D., Van Kessel A. G., Riegman P., Lekanne Deprez R., Zwarthoff E., Hagemeijer A., Grosveld G. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 1995; 10: 1511–1519
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Rowley J. D. Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization. Genes, Chromosomes and Cancer 1995; 12: 66–69
   PubMed Web of Science ®Google Scholar
• Papadopoulos P., Ridge S. A., Boucher C. A., Stocking C., Wiedemann L. M. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 1995; 55: 34–38
   PubMed Web of Science ®Google Scholar
• Wlodarska I., Mecucci C., Marynen P., Guo C., Franckx D., La Starza R., Aventin A., Bosly A., Martelli M. F., Cassiman J. J., Van Den Berghe H. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation ot its variant t(10;12)(q24;p13). Blood 1995; 85: 2848–2852
   PubMed Web of Science ®Google Scholar
• HÖGlund M., Johansson B., Pedersen-Bjergaard J., Marynen P., Mitelman F. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion, of KIPI, rearrangement of TEL, and amplification of CCND2. Blood 1996; 87: 324–330
   PubMed Web of Science ®Google Scholar
• Ohki M. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia. Semin. Cancer Biol. 1993; 4: 369–75
   PubMed Web of Science ®Google Scholar
• Meyers S., Hiebert S. W. Indirect and direct disruption of transcriptional regulation in cancer, E2F and AML-1. Crit. Rev. Euk. Gene Exp. 1996; 5: 365–383
   Web of Science ®Google Scholar
• Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., Gromer Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994; 23: 425–432
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 1991; 88: 10431–10434
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Ohira M., Shimizu K., Mitani K., Hirai H., Imai T., Yokoyama K., Soeda E., Ohki M. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nuc. Ac. Res. 1995; 23: 2762–2769
   PubMed Web of Science ®Google Scholar
• Nucifora G., Rowley J. D. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995; 86: 1–14
   PubMed Web of Science ®Google Scholar
• Meyers S., Noel L., Hiebert S. W. The t(8;21) fusion protein interferes with AML1B dependent transcriptional activation. Mol. Cell. Biol. 1995; 15: 1974–1982
   PubMed Web of Science ®Google Scholar
• Tanaka T., Tanaka K., Ogawa S., Kurokawa M., Mitani K., Nishida J., Shibata Y., Yazaki Y., Hirai H. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J. 1995; 14: 341–350
   PubMed Web of Science ®Google Scholar
• Tanaka T., Mitani K., Kurokawa M., Ogawa S., Tanaka K., Nishida J., Yazaki Y., Shibata Y., Hirai H. Dual fonctions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. 1995; 15: 2383–2392
   PubMed Web of Science ®Google Scholar
• Liu P. P., Hajra A., Wijmenga C., Collins F. S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995; 85: 2289–2302
   PubMed Web of Science ®Google Scholar
• Romana S. P., Poirel H., Le Coniat M., Flexor M.-A., MauchauffÉ M., Jonveaux P., Macintyre E. A., Berger R., Bernard O. A. High frequency of t(12;21) in childhood B lineage acute leukemia. Blood 1995; 86: 4263–4269
   PubMed Web of Science ®Google Scholar
• Raynaud S., CavÉ H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal-Giroux C., Guo C., Vilmer E., Marynen P., Grandchamp B. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alteration found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891–2899
   PubMed Web of Science ®Google Scholar
• Shurtleff S. A., Buijs A., Behm F. G., Rubnitz J. E., Raimondi S. C., Hancock M. L., Chan G. C.-H., Pui C.-H., Grosveld G., Downing J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989
   PubMed Web of Science ®Google Scholar
• CavÉ H., GÉRard B., Martin E., Guidal C., Devaux I., Weissenbach J., Elion J., Vilmer E., Grandchamp B. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from P27KIP1. Blood 1995; 86: 3869–3875
   PubMed Web of Science ®Google Scholar
• Stegmaier K., Pendse S., Barker F. G., Bray-Ward P., Ward D. C., Montgomery K. T., Krauter K. S., Reynolds C., Sklar J., Donnelly M., Bohlander S. K., Rowley J. D., Sallan S. E., Gilliland D. G., Golub T. R. Frequent loss of heterozygoty at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 38–44
   PubMed Web of Science ®Google Scholar
• Romana S. P., Le Coniat M., Poirel H., Marynen P., Bernard O. A., Berger R. Deletion of the short arm of the chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167–170
   PubMed Web of Science ®Google Scholar
• Knudson A. G. J. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Harja A., Liu P. P., Speck N. A., F S. C. Overexpression of Core-Binding Factor α (CBFα) reverses cellular transformation by the CBFβ-Smooth muscle myosin heavy chain chimeric oncoprotein. Mol. Cell. Biol. 1995; 15: 4980–4989
   PubMed Web of Science ®Google Scholar
• Hiebert S. W., Sun W.-H., Davis N., Golub T., Shurtleff S., Buijs A., Downing J. R., Grosveld G., Roussel M., Gilliland G. D., Lenny N., Meyers S. The t(12;21) converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 1996; 16: 1349–1355
   PubMed Web of Science ®Google Scholar